Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Furanone refers to a class of heterocyclic organic compounds characterized by a five-membered ring containing one oxygen atom and a carbonyl group, existing commonly as 2-furanone or 3-furanone isomers. In the fields of pharmacology and biotechnology, furanone is recognized as a significant chemical scaffold or ligand class rather than a therapeutic target like a receptor or enzyme. Naturally occurring furanones, such as those derived from the marine alga Delisea pulchra, are widely studied for their ability to inhibit bacterial quorum sensing by interacting with LuxR-type proteins, which disrupts biofilm formation and virulence without necessarily killing the bacteria. In human medicine, the furanone moiety is a structural component of several important molecules, including ascorbic acid (Vitamin C) and the selective COX-2 inhibitor rofecoxib. While rofecoxib demonstrated potent anti-inflammatory effects by targeting the COX-2 enzyme, it was famously withdrawn from the market due to increased cardiovascular risks associated with the furanone-based class of nonsteroidal anti-inflammatory drugs (NSAIDs). Because the term identifies a molecular structure or scaffold found in drugs and natural products rather than a biological macromolecule, it is technically misclassified as a therapeutic target.
Furanones primarily act as ligands or inhibitors rather than biological targets; for example, brominated furanones competitively bind to bacterial LuxR-type receptors to inhibit quorum sensing, while furanone derivatives like rofecoxib inhibit the cyclooxygenase-2 (COX-2) enzyme by binding to its active site.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Furanone.